08:00 , Nov 19, 2012 |  BC Week In Review  |  Company News

Boulder Diagnostics sales and marketing update

Boulder Diagnostics launched its SpiroFind in vitro diagnostic test to detect active Lyme borreliosis infection. The test, which measures cellular immune response to a challenge with the Borrelia bacterium and has CE Mark approval, is...
08:00 , Jan 30, 2012 |  BC Week In Review  |  Company News

Boulder Diagnostics, Portland State University deal

Boulder Diagnostics and the university partnered to develop rapid diagnostic tests for homocysteine and related compounds based on dye technology developed by the university. The partners said the dye will be used for a variety...
08:00 , Jan 18, 2010 |  BC Week In Review  |  Company News

Boulder Diagnostics Inc., Multimmune deal

Boulder Diagnostics will develop a blood-based heat shock protein 70 (Hsp70) lateral flow point-of-care test for Multimmune to determine which patients would benefit from hsp-70-derived treatments. The test will also evaluate the correlation of elevated...